Overall, our research for the first time defines TRIM6 as a negative regulator of ferroptosis in the lung cancer cells, and TRIM6 overexpression enhances the resistance of human lung cancer cells to chemotherapeutic drugs. The gene discussed is TRIM6; the disease is lung carcinoma.